These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16404786)

  • 61. Risperidone-induced Pisa syndrome.
    Jagadheesan K; Nizamie SH
    Aust N Z J Psychiatry; 2002 Feb; 36(1):144. PubMed ID: 11929457
    [No Abstract]   [Full Text] [Related]  

  • 62. Combination of clozapine and maprotiline in refractory psychotic depression.
    Hrdlicka M
    Eur Psychiatry; 2002 Dec; 17(8):484. PubMed ID: 12504267
    [No Abstract]   [Full Text] [Related]  

  • 63. A naturalistic study of risperidone maintenance treatment of outpatients with severe mental illness.
    Megna JL; Dewan M
    Psychiatr Serv; 1999 Aug; 50(8):1084-6. PubMed ID: 10445661
    [TBL] [Abstract][Full Text] [Related]  

  • 64. "Awakenings" effect with risperidone.
    Stip E; Tourjman V; Lew V; Fabian J; Cormier H; Landry P; Lalonde P; Cournoyer J
    Am J Psychiatry; 1995 Dec; 152(12):1833. PubMed ID: 8526260
    [No Abstract]   [Full Text] [Related]  

  • 65. Risperidone questioned as dementia first-line treatment.
    Saxe T
    Geriatrics; 2004 Feb; 59(2):11; author reply 11-2. PubMed ID: 14989589
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 67. Risperidone long-acting injection and Huntington's disease: case series with significant psychiatric and behavioural symptoms.
    Johnston TG
    Int Clin Psychopharmacol; 2011 Mar; 26(2):114-9. PubMed ID: 21119522
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol.
    Blazer DG
    Am J Geriatr Psychiatry; 2004; 12(6):658-9; author reply 659-60. PubMed ID: 15545335
    [No Abstract]   [Full Text] [Related]  

  • 69. Delusional wife: a case of diagnostic ambiguity and treatment challenge.
    Ose BL; Pandurangi AK; Gorman JM
    J Psychiatr Pract; 2005 May; 11(3):205-11. PubMed ID: 15920395
    [No Abstract]   [Full Text] [Related]  

  • 70. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis.
    van Nimwegen-Campailla L; van Beveren N; Laan W; van den Brink W; Linszen D; de Haan L
    Pharmacopsychiatry; 2010 Nov; 43(7):281. PubMed ID: 20839158
    [No Abstract]   [Full Text] [Related]  

  • 72. Return of menstruation after switching from risperidone to olanzapine.
    Gazzola LR; Opler LA
    J Clin Psychopharmacol; 1998 Dec; 18(6):486-7. PubMed ID: 9864085
    [No Abstract]   [Full Text] [Related]  

  • 73. Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.
    Shim JC; Choe BM; Kim JG; Jae YM; Kim HC; Kim SG; Oh MK; Kelly DL; Conley RR
    J Clin Psychopharmacol; 2007 Aug; 27(4):400-1. PubMed ID: 17632229
    [No Abstract]   [Full Text] [Related]  

  • 74. Fluvoxamine for psychosis in Alzheimer's disease.
    Levkovitz Y; Bloch Y; Kaplan D; Diskin A; Abramovitchi I
    J Nerv Ment Dis; 2001 Feb; 189(2):126-9. PubMed ID: 11225688
    [No Abstract]   [Full Text] [Related]  

  • 75. Induction of mania by risperidone resistant to mood stabilizers.
    Barkin JS; Pais VM; Gaffney MF
    J Clin Psychopharmacol; 1997 Feb; 17(1):57-8. PubMed ID: 9004061
    [No Abstract]   [Full Text] [Related]  

  • 76. Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis.
    Sajatovic M; Mullen JA; Sweitzer DE
    J Clin Psychiatry; 2002 Dec; 63(12):1156-63. PubMed ID: 12523876
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Injection site pain with long-acting risperidone.
    Pinninti NR; Mago R
    J Clin Psychiatry; 2005 May; 66(5):656-7; author reply, 657. PubMed ID: 15889958
    [No Abstract]   [Full Text] [Related]  

  • 78. Risperidone in the treatment of psychotic depression.
    Goto M; Yoshimura R; Kakihara S; Shinkai K; Yamada Y; Kaji K; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):701-7. PubMed ID: 16580110
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Benefit of early prescription of Risperdal RLAI: a study of 25 psychotic patients hospitalised for the first time in their district service].
    Viala A; Cornic F; Beghelli F; Vacheron MN
    Therapie; 2010; 65(6):579-80. PubMed ID: 21176766
    [No Abstract]   [Full Text] [Related]  

  • 80. The difference between the formal and the functional dose: the case of the patient on thioridazine and fluvoxamine.
    Preskorn SH
    J Psychiatr Pract; 2005 May; 11(3):192-6. PubMed ID: 15920392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.